Could steroids offer a solution for acute respiratory distress syndrome (ARDS) that fails to resolve? The study by Meduri et al. evaluated the use of prolonged methylprednisolone therapy in patients with unresolved acute respiratory distress syndrome (ARDS). The randomized trial found that the use of methylprednisolone in ARDS patients led to improvements in pulmonary function and a reduction in the duration of mechanical ventilation, with no significant increase in infections. However, the potential risks of prolonged steroid use, including hyperglycemia and immunosuppression, require careful monitoring. This study highlighted the potential therapeutic benefits of corticosteroids for ARDS, especially in cases where conventional therapies failed to resolve the condition.